An Affordable Anti-Malarial / Um medicamento para malária a preço mais acessível
Wednesday, August 20th, 2008From Drugs for Neglected Diseases initiative (DNDi): Sanofi-aventis and DNDi welcome the Clinton Foundation announcement on ACTs and commit to providing fixed-dose combination “ASAQ” at equally low prices Sanofi-aventis and the non-profit Drugs for Neglected Diseases initiative (DNDi) welcome the agreement announced by Clinton Foundation HIV/AIDS Initiative (CHAI) to reduce the volatility and the price […]